Letrozole

Manufacturer: Hilma Biocare
Active Half-life (Days): 2-3 days
Group: Aromatase Inhibitor
Subgroup: Oral/Tablets
Dosage: 2.5 mg/tab
Application (Men): 0.5 to 1 mg throughout 1 to 3 days
Product Pack: 30 tab
Retains Water: No
Aromatization: No

Content (Active): Letrozole

Product Description

Letrozole by Hilma Biocare is a powerful non-steroidal, selective aromatase inhibitor. Initially developed as a treatment for post-menopausal women with breast cancer, it has become a popular choice among athletes due to its strong anti-estrogenic effects. Compared to Anastrozole (Arimidex), Letrozole is up to five times more potent, making it especially effective in managing estrogen-related side effects from anabolic steroid use. It significantly suppresses estrogen levels, making it a crucial tool in controlling aromatization in bodybuilding.

Effects

Letrozole provides the following benefits for athletes:

• Near Total Estrogen Suppression: Effectively reduces estrogen levels, minimizing estradiol-related side effects.
• Prevents Aromatization: Helps avoid estrogenic issues such as gynecomastia and water retention.
• Improved Muscle Definition: Reduces bloating and enhances muscle hardness and definition.

Stacking

Letrozole is most effective when used during Post-Cycle Therapy (PCT) but can also be stacked with other compounds such as Clomiphene or anabolic steroids to optimize anti-estrogenic effects throughout a cycle.